Literature DB >> 27321057

Glomerular disease: Membranous nephropathy and the Henle-Koch postulates.

Hans-Joachim Anders1, Claudio Ponticelli2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27321057     DOI： 10.1038/nrneph.2016.86

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.

Authors:  Nicola M Tomas; Laurence H Beck; Catherine Meyer-Schwesinger; Barbara Seitz-Polski; Hong Ma; Gunther Zahner; Guillaume Dolla; Elion Hoxha; Udo Helmchen; Anne-Sophie Dabert-Gay; Delphine Debayle; Michael Merchant; Jon Klein; David J Salant; Rolf A K Stahl; Gérard Lambeau
Journal:  N Engl J Med       Date:  2014-11-13       Impact factor: 91.245

2.  Early-childhood membranous nephropathy due to cationic bovine serum albumin.

Authors:  Hanna Debiec; Florence Lefeu; Markus J Kemper; Patrick Niaudet; Georges Deschênes; Giuseppe Remuzzi; Tim Ulinski; Pierre Ronco
Journal:  N Engl J Med       Date:  2011-06-02       Impact factor: 91.245

3.  Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies.

Authors:  Hanna Debiec; Vincent Guigonis; Béatrice Mougenot; Fabrice Decobert; Jean-Philippe Haymann; Albert Bensman; Georges Deschênes; Pierre M Ronco
Journal:  N Engl J Med       Date:  2002-06-27       Impact factor: 91.245

4.  A Mechanism for Cancer-Associated Membranous Nephropathy.

Authors:  Elion Hoxha; Thorsten Wiech; Phillip R Stahl; Gunther Zahner; Nicola M Tomas; Catherine Meyer-Schwesinger; Ulrich Wenzel; Matthias Janneck; Oliver M Steinmetz; Ulf Panzer; Sigrid Harendza; Rolf A K Stahl
Journal:  N Engl J Med       Date:  2016-05-19       Impact factor: 91.245

5.  Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy.

Authors:  Elion Hoxha; Ina Thiele; Gunther Zahner; Ulf Panzer; Sigrid Harendza; Rolf A K Stahl
Journal:  J Am Soc Nephrol       Date:  2014-03-07       Impact factor: 10.121

Review 6.  Pathophysiological advances in membranous nephropathy: time for a shift in patient's care.

Authors:  Pierre Ronco; Hanna Debiec
Journal:  Lancet       Date:  2015-05-16       Impact factor: 79.321

Review 7.  Membranous nephropathy: A fairy tale for immunopathologists, nephrologists and patients.

Authors:  Pierre Ronco; Hanna Debiec
Journal:  Mol Immunol       Date:  2015-11       Impact factor: 4.407

8.  M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.

Authors:  Laurence H Beck; Ramon G B Bonegio; Gérard Lambeau; David M Beck; David W Powell; Timothy D Cummins; Jon B Klein; David J Salant
Journal:  N Engl J Med       Date:  2009-07-02       Impact factor: 91.245

9.  Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy.

Authors:  Nicola M Tomas; Elion Hoxha; Anna T Reinicke; Lars Fester; Udo Helmchen; Jens Gerth; Friederike Bachmann; Klemens Budde; Friedrich Koch-Nolte; Gunther Zahner; Gabriele Rune; Gerard Lambeau; Catherine Meyer-Schwesinger; Rolf A K Stahl
Journal:  J Clin Invest       Date:  2016-05-23       Impact factor: 14.808

Review 10.  Glomerular diseases and cancer: evaluation of underlying malignancy.

Authors:  Antonello Pani; Camillo Porta; Laura Cosmai; Patrizia Melis; Matteo Floris; Doloretta Piras; Maurizio Gallieni; Mitchell Rosner; Claudio Ponticelli
Journal:  J Nephrol       Date:  2015-10-26       Impact factor: 3.902
  10 in total
  2 in total

Review 1.  Primary membranous nephropathy: an endless story.

Authors:  Ponticelli Claudio
Journal:  J Nephrol       Date:  2022-10-17       Impact factor: 4.393

2.  Urine proteomics of primary membranous nephropathy using nanoscale liquid chromatography tandem mass spectrometry analysis.

Authors:  Lu Pang; Qianqian Li; Yan Li; Yi Liu; Nan Duan; Haixia Li
Journal:  Clin Proteomics       Date:  2018-02-07       Impact factor: 3.988
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.